Medizinische Universität Graz - Research portal

Go directly to the nagivation.
Go directly to the content.

Navigation/Search

Selected Publication:

Lahousen, M; Pickel, H; Haas, J.
Lithium carbonate--a preventive agent against leukopenia during cytostatic therapy
Wien Klin Wochenschr. 1984; 96(19):739-741
Web of Science PubMed Google Scholar

Leading authors Med Uni Graz: Lahousen Manfred
Co-authors Med Uni Graz: Haas Josef
Altmetrics:
Dimensions Citations:
Plum Analytics:
Abstract:: A group of 51 patients treated surgically for ovarian carcinoma was randomly subdivided to test the efficacy of lithium carbonate in the prevention of leucopenia during systemic chemotherapy. In 26 patients receiving sequential lithium carbonate the side effect of myelosuppression was mitigated and the leucocyte count during treatment, which determines the dosage of the cytostatic drugs, was significantly higher in this group. It was, thus, possible to reduce the number of cytostatic courses of treatment in the lithium group in comparison with the treatment courses in the 25 control patients. Lithium therapy had to be discontinued due to side effects in seven patients, which were then excluded from the trial.
Find related publications in this database (using NLM MeSH Indexing): Cyclophosphamide - adverse effects; Doxorubicin - adverse effects; Female -; Humans -; Leukopenia - chemically induced Leukopenia - prevention and control; Lithium - adverse effects Lithium - therapeutic use; Lithium Carbonate -; Ovarian Neoplasms - drug therapy; Tremor - chemically induced